This coverage uncertainty creates barriers for patients ready to start treatment, as approval timelines are unpredictable and denials are common
Do not use if inner seal is missing or damaged.
Retatrutide is a single-molecule peptide that activates three different metabolic receptors at once: GLP-1, GIP and glucagon
Discuss risks/benefits with the provider Medications That May Interact: Diabetes medications (insulin, sulfonylureas): Can increase the risk of hypoglycemia (low blood sugar) Dose adjustments needed Oral hormonal contraceptives (birth control pills): Tirzepatide may decrease effectiveness, especially after the first dose and dose increases Switch to a non-oral contraceptive or add a barrier method for 4 weeks after starting and after each dose increase Other GLP-1 medications: Cannot use tirzepatide with Ozempic, Wegovy, Saxenda, Victoza, Mounjaro, Zepbound, Byetta, or Bydureon Cannot combine with other weight loss medications or supplements without provider approval Mental Health Screening During the telehealth consultation, providers screen for: History of depression Suicidal thoughts or behavior Eating disorders (binge eating disorder, bulimia, and anorexia history) GLP-1 medications carry a warning about suicidal behavior and ideation
PCs are frequently cited for their ability to improve insulin sensitivity in experimentally induced diabetic rats (Antoni et al., 2017
